For patients with high cholesterol, Praluent, also known by its generic name, alirocumab, is the new FDA approved drug that is effective at improving liver function to lower bad cholesterol (Goldschmidt). Unlike other available medication in the market, Praluent is a completely new class of drug that enhance the lives of many individuals and provides an alternative method for treating cholesterol that will appeal to patients who do not see results from their current medication or experience severe side effects.
Most current statins, like Lipitor, block the liver’s production of bad cholesterol. Praluent uses a different method in which antibodies target a protein called PCSK9 that generally maintains high levels of cholesterol in the liver…